Parker-Hannifin Reports Record Q3 Results, Beats Estimates, and Raises Full-Year Sales & EPS Outlook
PH sits 57% above its 52-week low of $583.89.
Summary
Parker-Hannifin announced record fiscal Q3 results, beating estimates with $5.5 billion in sales and $8.17 adjusted EPS, and raised its full-year sales and adjusted EPS guidance.
Key Events · Earnings and Guidance · PH
-
Record Q3 Financial Performance
Sales increased 11% to a record $5.5 billion, with organic sales up 6.5%. Adjusted diluted EPS rose 18% to a record $8.17, surpassing prior year figures despite a one-time tax benefit in the comparative period.
-
Raised Full-Year Outlook
The company increased its fiscal 2026 guidance, now expecting reported sales growth of 7% and adjusted EPS of $31.20, reflecting mid-teens adjusted EPS growth for the year.
-
Strong Order Growth and Backlog
Overall order rates grew 9% in the quarter, contributing to a record backlog of $12.5 billion, indicating robust future demand across its diversified industrial and aerospace segments.
-
Significant Cash Flow and Share Repurchases
Year-to-date cash flow from operations reached a record $2.6 billion, representing 16.7% of sales. The company also repurchased $275 million of its common shares during the quarter.
Analysis · PH · Manufacturing
Parker-Hannifin reported strong fiscal third-quarter results, exceeding analyst expectations for sales and adjusted earnings per share. The company achieved record sales of $5.5 billion and an 18% increase in adjusted EPS to $8.17. Critically, management raised its full-year fiscal 2026 outlook for both reported sales growth (to 7%) and adjusted EPS (to $31.20), signaling continued confidence in its operational performance and market conditions. This positive update, following recent news of strong Q3 results, provides detailed financial figures and a more optimistic forward-looking perspective, which is a significant driver for investor sentiment.
At the time of this filing, PH was trading at $917.50 on NYSE in the Manufacturing sector, with a market capitalization of approximately $119.6B. The 52-week trading range was $583.89 to $1,034.96. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.